Overview
- 3 inspections across 3 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2025-09-19.
At a glance
Inspections
3
Sites
3
Observations
0
Career since
May 2023
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Lupin Limited | 19 Sep 2025 | Human Drugs | On file |
| Alvotech HF | 19 Jan 2024 | Human Drugs | On file |
| Takeda Pharmaceutical Company Limited | 24 May 2023 | Human Drugs | On file |
Sites inspected
Lupin LimitedPune, India1 insp.
Alvotech HFReykjavik, Iceland1 insp.
Takeda Pharmaceutical Company LimitedHikari, Japan1 insp.
Co-investigators
Investigators who share inspections with this person.
Hamet M Toure1 shared
Scott C Lute1 shared
Michael Shanks1 shared
Holly Brevig1 shared
Vidya B Pai1 shared
Thuy T Nguyen1 shared
Laurimer Kuilan-Torres1 shared
Full investigator report
Get the verbatim findings behind Bingchen Du's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site